Orange Grove Bio
Cincinnati, US · Founded 2019 · Delaware LLC · 29 employees on LinkedIn · 2 known investors
Find your way into Orange Grove Bio
125 people in our graph share verified history with the Orange Grove Bio team — schools, employers, funds. One of them is your warm intro.
Orange Grove Bio is a biotech venture firm that builds and backs cell therapy and immuno-oncology companies, forming subsidiary companies (subcos) such as Ipinovyx and DomainOne Therapeutics. It operates in the biopharmaceutical and life sciences investment space.
Founders & leadership

Investors · 2
Reported raises · per SEC filings
Form D private placements$16.6M disclosed across 1 round · 2022
▶$16.6MraisedAug 2022 · 15 investors · Other Health CareRule 506(b)
- Marc AppelExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $16.6M
- First sale
- Aug 2022
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Orange Grove Bio went on to found or lead other companies.
Competitors · 4
by search overlapCompanies competing with Orange Grove Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Orange Grove Bio do?
- Orange Grove Bio is a biotech venture firm that builds and backs cell therapy and immuno-oncology companies, forming subsidiary companies (subcos) such as Ipinovyx and DomainOne Therapeutics. It operates in the biopharmaceutical and life sciences investment space.
- Who are Orange Grove Bio's investors?
- Orange Grove Bio's investors include AlleyCorp, Alley Robotics Ventures.
- How much funding has Orange Grove Bio raised?
- Orange Grove Bio has disclosed $16.6M raised across 1 round.
- Where is Orange Grove Bio headquartered?
- Orange Grove Bio is headquartered in Cincinnati, US.





